{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:42:35Z","timestamp":1793421755394,"version":"4.5.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DMSO"],"DOI":"10.2147\/dmso.s212003","type":"journal-article","created":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:43:29Z","timestamp":1571003009000},"page":"2125-2136","source":"Crossref","is-referenced-by-count":94,"title":["<p>Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician\u2019s Guide<\/p>"],"prefix":"10.2147","volume":"Volume 12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-6955","authenticated-orcid":true,"given":"Bryce C","family":"Simes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-5650","authenticated-orcid":true,"given":"Gordon G","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,10]]},"container-title":["Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=53287","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=53287","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T21:43:30Z","timestamp":1571003010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/sodium-glucose-cotransporter-2-sglt2-inhibitors-a-clinicians-guide-peer-reviewed-article-DMSO"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dmso.s212003","relation":{},"ISSN":["1178-7007"],"issn-type":[{"value":"1178-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}